Stay ahead of the market with innovations from Hologic!
Is this email not displaying correctly?
View it in your browser.
Hologic set the standard for digital mammography, then revolutionized breast screening with Selenia® Dimensions®, the first FDA-approved digital breast tomosynthesis system. The new 3Dimensions™ mammography system is designed to be our most advanced 3D Mammography™ system, representing the next evolution of our 3D™ platform.

ACCURATE RESULTS: The 3Dimensions system offers the clinically proven Genius™ 3D Mammography™ exam, which is more accurate than conventional 2D mammograms, detecting 20-65% more invasive breast cancers.§ It also reduces callbacks by up to 40% compared to 2D alone.2,5 The 3D™ exam is also the only breast tomosynthesis exam FDA approved as superior for women with dense breasts compared to 2D alone.1-2

PATIENT COMFORT: The 3Dimensions system includes the SmartCurve™ breast stabilization system**, which is proven to provide a more comfortable mammography experience preferred by 93% of women over standard flat-paddle compression.6
3Dimensions mammography system
3Dimensions mammography system
SUPERIOR CLARITY: The 3Dimensions system is designed to be the fastest and highest-resolution breast tomosynthesis system available. It is designed to be equipped with our Clarity HD high-resolution 3D™ imaging**, once commercially available, which provides the option to activate our highest resolution 3D™ images without compromising our fast 3.7 second scan time, or low dose.


Visit us at Booth 4705.

Skeletal Presentation:  Enhancements for the Fluoroscan ® InSightTM FD Mini C-Arm Extremities Imaging System
Monday, Tuesday and Wednesday — 12:30pm & 3:30pm
**Upon FDA approval and/or commercial availability
The Genius™ 3D Mammography™ exam (a.k.a. Genius™ exam) is acquired on the Hologic® 3D Mammography™ system and consists of a 2D and 3D™ image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D™ image set. The Genius™ exam is only available on the Hologic® 3D Mammography™ system. Please consult your physician for a full list of benefits and risks associated with mammography.
§ Results from Friedewald, SM, et al. "Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia Dimensions on screening outcomes. Individual results may vary. The study found an average 41% increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D™ mammograms acquired with the Hologic 3D Mammography™ System versus women receiving 2D FFDM mammograms only.
  1. FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005.
  2. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.
  3. Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736.
  4. Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63.
  5. Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.
  6. Smith, A. Improving Patient Comfort in Mammography. Hologic WP-00019 Rev 001 (2017)

EMB-01044 Rev.001 (11/17) Hologic Inc. ©2017 All rights reserved. Hologic, 3D, 3D Mammography, 3Dimensions, Genius, SmartCurve, SecurView, Selenia, The Science of Sure and associated logos are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries. This information is intended for medical professionals in the U.S. and other markets and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, please contact your local Hologic representative.
Copyright © 2017, All rights reserved.

Our mailing address is:
250 Campus Drive
Marlborough, MA 01751